Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms

• Amgen says no concerns around weight loss drug’s bone density data after stock falls

  Business - CNBC - November 13
• 

  New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

  Business - The New York Times - 18 hours ago

• Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

  Business - CNBC - 17 hours ago

• AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

  Business - MarketWatch - November 5

More from MarketWatch

• Jobless claims slide to 7-month low. Businesses not cutting many jobs.

  Business - MarketWatch - 4 minutes ago

• This $22 billion robotics company’s stock is tumbling as accounting errors found

  Business - MarketWatch - 8 minutes ago

• Durable-goods orders barely budge. No sign manufacturing slump is ending.

  Business - MarketWatch - 10 minutes ago

• Is the stock market open on Black Friday?

  Business - MarketWatch - 12 minutes ago

• Pony AI’s IPO debut could set the stage for more Chinese listings as thaw eases

  Business - MarketWatch - 14 minutes ago